ATE246683T1 - Indan- oder dihydroindol-derivate - Google Patents
Indan- oder dihydroindol-derivateInfo
- Publication number
- ATE246683T1 ATE246683T1 AT97949999T AT97949999T ATE246683T1 AT E246683 T1 ATE246683 T1 AT E246683T1 AT 97949999 T AT97949999 T AT 97949999T AT 97949999 T AT97949999 T AT 97949999T AT E246683 T1 ATE246683 T1 AT E246683T1
- Authority
- AT
- Austria
- Prior art keywords
- compounds
- indaneous
- optionally substituted
- dihydroindole
- dopamine
- Prior art date
Links
- LPAGFVYQRIESJQ-UHFFFAOYSA-N indoline Chemical class C1=CC=C2NCCC2=C1 LPAGFVYQRIESJQ-UHFFFAOYSA-N 0.000 title abstract 2
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 abstract 4
- 150000001875 compounds Chemical class 0.000 abstract 2
- 229960003638 dopamine Drugs 0.000 abstract 2
- 230000000862 serotonergic effect Effects 0.000 abstract 2
- 208000019901 Anxiety disease Diseases 0.000 abstract 1
- 208000012902 Nervous system disease Diseases 0.000 abstract 1
- 208000028017 Psychotic disease Diseases 0.000 abstract 1
- 230000036506 anxiety Effects 0.000 abstract 1
- PQNFLJBBNBOBRQ-UHFFFAOYSA-N benzocyclopentane Natural products C1=CC=C2CCCC2=C1 PQNFLJBBNBOBRQ-UHFFFAOYSA-N 0.000 abstract 1
- 230000002301 combined effect Effects 0.000 abstract 1
- 125000003392 indanyl group Chemical class C1(CCC2=CC=CC=C12)* 0.000 abstract 1
- 239000003446 ligand Substances 0.000 abstract 1
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 abstract 1
- 208000020016 psychiatric disease Diseases 0.000 abstract 1
- 125000006850 spacer group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/62—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
- C07D317/66—Nitrogen atoms not forming part of a nitro radical
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Addiction (AREA)
- Cardiology (AREA)
- Anesthesiology (AREA)
- Hospice & Palliative Care (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Indole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK146996 | 1996-12-20 | ||
| PCT/DK1997/000588 WO1998028290A1 (en) | 1996-12-20 | 1997-12-19 | Indane or dihydroindole derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE246683T1 true ATE246683T1 (de) | 2003-08-15 |
Family
ID=8105168
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT97949999T ATE246683T1 (de) | 1996-12-20 | 1997-12-19 | Indan- oder dihydroindol-derivate |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US6331544B1 (de) |
| EP (1) | EP0946538B1 (de) |
| JP (1) | JP2001506657A (de) |
| AT (1) | ATE246683T1 (de) |
| AU (1) | AU5311098A (de) |
| CA (1) | CA2275299C (de) |
| DE (1) | DE69724000T2 (de) |
| DK (1) | DK0946538T3 (de) |
| ES (1) | ES2205267T3 (de) |
| PT (1) | PT946538E (de) |
| WO (1) | WO1998028290A1 (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2003524571A (ja) | 1997-07-25 | 2003-08-19 | ハー・ルンドベック・アクチエゼルスカベット | インドール−及び２，３−ジヒドロインドール誘導体、その製造方法及びその使用方法 |
| EP1228064A1 (de) * | 1999-11-08 | 2002-08-07 | Wyeth | N-aryl-(homopiperazinyl)-cyclohexyl aminen als 5-ht überträger |
| CA2501781A1 (en) * | 2002-10-22 | 2004-05-06 | Drugabuse Sciences S.A.S. | Treatment of cognitive impairment using a selective dopamine d1 receptor agonist |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2692264B1 (fr) * | 1992-06-12 | 1994-08-05 | Adir | Nouvelles piperazines 1,4-disubstituees, leur procede de preparation et les compositions pharmaceutiques les contenant. |
| ZA954689B (en) | 1994-06-08 | 1996-01-29 | Lundbeck & Co As H | 4-Aryl-1-(indanmethyl dihydrobenzofuranmethyl or dihydrobenzothiophenemethyl) piperidines tetrahydropyridines or piperazines |
| FR2734819B1 (fr) * | 1995-05-31 | 1997-07-04 | Adir | Nouveaux composes de la piperazine, de la piperidine et de la 1,2,5,6-tetrahydropyridine, leur procede de preparation et les compositions pharmaceutiques les contenant |
-
1997
- 1997-12-19 AT AT97949999T patent/ATE246683T1/de not_active IP Right Cessation
- 1997-12-19 WO PCT/DK1997/000588 patent/WO1998028290A1/en not_active Ceased
- 1997-12-19 EP EP97949999A patent/EP0946538B1/de not_active Expired - Lifetime
- 1997-12-19 PT PT97949999T patent/PT946538E/pt unknown
- 1997-12-19 DE DE69724000T patent/DE69724000T2/de not_active Expired - Fee Related
- 1997-12-19 ES ES97949999T patent/ES2205267T3/es not_active Expired - Lifetime
- 1997-12-19 JP JP52826398A patent/JP2001506657A/ja not_active Ceased
- 1997-12-19 AU AU53110/98A patent/AU5311098A/en not_active Abandoned
- 1997-12-19 DK DK97949999T patent/DK0946538T3/da active
- 1997-12-19 CA CA002275299A patent/CA2275299C/en not_active Expired - Fee Related
- 1997-12-19 US US09/331,557 patent/US6331544B1/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| ES2205267T3 (es) | 2004-05-01 |
| PT946538E (pt) | 2003-12-31 |
| EP0946538B1 (de) | 2003-08-06 |
| EP0946538A1 (de) | 1999-10-06 |
| JP2001506657A (ja) | 2001-05-22 |
| WO1998028290A1 (en) | 1998-07-02 |
| DE69724000T2 (de) | 2004-07-22 |
| CA2275299A1 (en) | 1998-07-02 |
| AU5311098A (en) | 1998-07-17 |
| US6331544B1 (en) | 2001-12-18 |
| DE69724000D1 (de) | 2003-09-11 |
| DK0946538T3 (da) | 2003-11-03 |
| CA2275299C (en) | 2003-12-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE166650T1 (de) | Spiroazacyclischderivate als substanz p antagonisten | |
| PT641328E (pt) | Derivados aza-biciclicos em ponte como antagonistas da substancia p | |
| DE69725171D1 (de) | Substituierte pyrrolylverbindungen zur behandlung von entzündungen | |
| ATE269312T1 (de) | N-(amidinophenyl)-n'-(subst.)-3h-2,4- benzodiazepin-3-on derivative als faktor xa inhibitoren | |
| DE69926806D1 (de) | N-ureidoalkylpiperidine als modulatoren der aktivität der chemokinrezeptoren | |
| DE69926919D1 (de) | N-ureidoalkylpiperidine als modulatoren der aktivität der chemokinrezeptoren | |
| TR200101969T2 (tr) | Enflamasyon tedavisi için sübstitüe edilmiş benzopiran analogları. | |
| ATE192649T1 (de) | Stereochemische wortmanninderivate | |
| EA199700156A1 (ru) | Производные индола как антагонисты рецептора 5-нт | |
| ATE203515T1 (de) | Meta-substituierte phenylsulphonamidderivate | |
| NO20000521D0 (no) | 1-(N-fenylaminoalkyl)-piperazin derivater substituert i posisjon 2 på fenylringen | |
| ATE247639T1 (de) | Arylsubstituierte cyclische amine als selektive dopamin-d3-liganden | |
| DE69523155D1 (de) | Benzimidazolonderivate mit zentraler dopaminerger aktivität | |
| ES2073258T3 (es) | Nuevos derivados de la urea, su preparacion y su aplicacion en terapeutica. | |
| DE69530988D1 (de) | Benzimidazolderivate mit dopaminerger wirkung | |
| AP2001002188A0 (en) | 5HT1 antagonists for antidepressant therapy. | |
| ES2174113T3 (es) | Nuevos derivados de ((3-alcoxi-fenoxi)-etil)-dialquilamina y su utilizacion como anestesicos locales. | |
| DK0946538T3 (da) | Indan- eller dihydroindole derivater | |
| CA2241845A1 (en) | 4,5-dihydronaphth[1,2-c]isoxazoles and derivatives thereof having cns activity | |
| DE69604976D1 (de) | Herstellung von Diamanteinkristallen aus amorphen hydrogenierten Kohlstoff | |
| NO974155L (no) | Ny fremgangsmåte for fremstilling av 2,3-dihydrobenzofuranolderivater | |
| TR199901395T2 (xx) | Yeni karboksi ikameli siklik karboksamid t�revleri. | |
| NO962620L (no) | Nye mellomprodukter for syntese av L-aspartyl-D--aminoalkanoyl-(S)-N--alkylbenzylamider anvendbare son kunstige sötningsmidler | |
| DE69808922D1 (de) | Thiazolobenzoheterocyclen, ihre herstellung und diese enthaltende phatrmazeutische zubereitungen | |
| ATE243695T1 (de) | 5-bicycloindolverbindungen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 0946538 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |